Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Saturday, October 24, 2026
Advertising
About Us
Subscribe to Newsletter
Facebook
X
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
Home
Venture Capital
Venture Capital
Venture Capital
Estuary Biotherapeutics Launches with $103 Million to Advance Gene Therapies for Kidney Disease
Life Sciences Times
-
October 16, 2026
Venture Capital
Acta Pharmaceuticals Raises $24 Million to Advance Alzheimer’s Disease Treatments
Life Sciences Times
-
October 15, 2026
Venture Capital
Soufflé Therapeutics Raises $135 Million in Series B Financing to Advance RNA Therapies
Life Sciences Times
-
October 13, 2026
Venture Capital
Consano Bio Raises More Than $15 Million to Advance Chronic Sciatica Therapy
Life Sciences Times
-
October 5, 2026
Venture Capital
ai3Bio Launches With $48 Million Series A to Advance Autoimmune Disease Therapies
Life Sciences Times
-
September 29, 2026
Venture Capital
D&D Pharmatech Raises $51M in Series C Financing to Advance Potential Disease-Modifying Treatments for Neurodegenerative, Fibrotic, and Metabolic Diseases
Life Sciences Times
-
October 19, 2021
0
Venture Capital
Sofinnova Partners Raises €472 ($548) Million to Form Largest Early-Stage Healthcare VC Fund in Europe
Life Sciences Times
-
October 19, 2021
0
Venture Capital
Aditxt Announces Pricing of $4.25 Million Public Offering
Life Sciences Times
-
October 18, 2021
0
Venture Capital
Sanaby Health Acquisition Corp. I Announces Pricing of $150 Million Initial Public Offering
Life Sciences Times
-
October 15, 2021
0
Venture Capital
Culture Biosciences Raises $80M Series B to Tackle Demand for Large-Scale Biomanufacturing
Life Sciences Times
-
October 15, 2021
0
Venture Capital
Abalos Therapeutics Completes Series A Extension Bringing Total Raised to EUR 43 Million
Life Sciences Times
-
October 14, 2021
0
Venture Capital
Rectify Pharmaceuticals Launches with $100 Million Series A Financing from Atlas Venture, Omega Funds, Forbion, and Longwood Fund
Life Sciences Times
-
October 14, 2021
0
Venture Capital
CIBC Launches $450 Million Fund Focused on Venture Capital and Growth Equity Funds
Life Sciences Times
-
October 13, 2021
0
Venture Capital
Merck Begins Tender Offer to Acquire Acceleron Pharma Inc.
Life Sciences Times
-
October 12, 2021
0
Venture Capital
Pluto Biosciences Closes $1M Seed Round for Industry-first Collaborative Life Sciences Platform
Life Sciences Times
-
October 12, 2021
0
Venture Capital
Aceto Expands GMP Product Lines for Biopharmaceutical and Vaccine Manufacturing with Acquisition of A&C Bio Buffer
Life Sciences Times
-
October 12, 2021
0
Venture Capital
Aquant Announces $70 Million Series C Funding Round to Revolutionize the Service Industry Using Artificial Intelligence
Life Sciences Times
-
October 8, 2021
0
1
...
96
97
98
...
115
Page 97 of 115
Most Read
Alnylam Reports Promising Phase 1b Results for Experimental Huntington’s Disease Treatment
October 23, 2026
Zai Lab Reports Promising Early Results for Experimental Small Cell Lung Cancer Treatment
October 23, 2026
Takeda Reports Improved Survival in Phase 3 Trial of Experimental Gastric Cancer Treatment
October 23, 2026
Convergent Therapeutics Reports Promising Phase 2 Results for Prostate Cancer Treatment
October 23, 2026